The suboptimal specificity is due to small but significant fractions of TTF-1 positive cases in many common tumor entities such as adenocarcinomas of the colorectum, stomach, pancreas, prostate, ovary, and uterus, as well as urothelial carcinomas. Here, TTF1 is linked to adenocarcinoma.